IMV Inc IMVIF

IMV is like a box of chocolates.

[QM45]

IMV is like a box of chocolates, you never know what ya gonna get... 

Here is the "news" we have been so patiently waiting for over 5 months. 

Anyone hanging their hopes on the "end of summer" bomb shell should be sorely disappointed, it being Phase 1 initiation or preclinical studies results. 

If a tree falls in a forest and no one cares does it matter? I doubt it. 

End of 2020 is just another goal post moved by this management team wrt Phase 1. Preclinal studies published timeline in peer reviewed journal from initial "coming weeks" in May to "end of 2020" is laughable. 

It's hard to believe any of these so called "updates" by this stage. It seems anytime investor's frustration grows loud enough, they reluctantly throw a bone to the markets after promising pipe dreams for months. To say I have become sceptical of this  team's propaganda would be an understatement. 

It's great they got another 5M, better than nothing. That is the only concrete achievement. Everything else seems like a lot of BS justifying money grab by Ors and Co. from naive investors. 


See you at the end of 2020 Ors, let's see if that turns into another box of chocolates... 






I

[qwerty22]

All biotech looks like a box of chocolate, reality though a rollercoaster ride that could fall apart at any moment.  If this was BS I don't expect the NRC would step in with more support. There has to be something concrete here. Look the challenge studies is something new to contemplate. They are a great tool to measure efficacy pre-clinically. Good animal models didn't exist apr

[FastFF]

I bought this for a cancer cure - not the virusfest  Company has become. It's just a side show. I'll wait until the data comes, hopefully next couple months, therefore I don't react either way to the constant complaints. The good news is they raised money off this at 2X or 3X the price if no Covid. I sold 1/2 into the pump, now happy to see it drift lower - soon will be a good

[qwerty22]

Well the good thing from your perspective is cancer never stopped being the lead program in the minds of management. I think I would class COVID as another clinical program rather than a sideshow. It still has its benefits, it can still draw in non-dilutitive funding, it can still go some way to validating the technology, it's just not the 10 baggers dream.  

[LI33VESTREAM]

This post has been removed in accordance with Community Policy

[GrandSlam29]

I slightly disagree with those of you that are saying that the COVID Vaccine is merely a sideshow, Like many of you, I bought into the Company because of the potential cancer treatments and that arm os development is still progressing (albeit maybe at a slower pace). Nevertheless,, I read the latest announcement in a wholly positive way: Health Canada have now approved the ongoing

[antisense]

Investors are mainly  idiots who only care about short term profit (the quick flip).  I'm a huge critic of IMV but i saw this news release as 100% positive as well and couldnt be happier.  Moving to a phase 1/2 trial is HUGE news and basically allows us to skip phase 1 and move straight to phase 2.  Or look at it another way we just complete and passed phase 1 and are now

[RockLobster1]

I agree with you guys that the release was positive by and the market expectations are very high. And it's not like the cancer side is gone... Covid is an extra, and let me sell some at 8.50 to buy back later. It also can be an introduction to new investors who had never taken a look. But the way it trades makes me feel i have a box of onions sometimes...

[DaveInvestor59]

This stock is worse than a box of onions. It's not going to stop falling until its back to where it started. I'm out. Big waste of time and money following this for several months. Any other vaccine stock would have been better.

[qwerty22]

Depends what you mean by accelerated pathway. I think they've missed  "warp speed" by not being part of that first wave of vaccines. What HC want seems to be more safety and deep efficacy evidence which makes me think they've returned to something closer to business-as-usual for the second wave of vaccines, that could be a business-as-usual accelerated pathway but maybe not